EVELINA INGERSOLL: Open Payments
NPI 1124698527 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,167 in 126 payments from 19 companies in 2025. Trend: 2023 $1,723 · 2024 $1,949 · 2025 $3,167
Food & beverage: $2,414Consulting: $500Education: $253
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $782 |
| Journey Medical Corporation | 1 | $500 |
| Regeneron Healthcare Solutions, Inc. | 18 | $435 |
| GENZYME CORPORATION | 11 | $306 |
| UCB, Inc. | 14 | $263 |
| ABBVIE INC. | 21 | $248 |
| Novartis Pharmaceuticals Corporation | 7 | $168 |
| Organon LLC | 7 | $91 |
| Incyte Corporation | 3 | $76 |
| Amgen Inc. | 3 | $54 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, COSENTYX, OPZELURA, RINVOQ, OTEZLA.
Industry payments across FL — which companies pay providers there.
